AbbVie traded at $162.12 this Tuesday June 4th, increasing $2.02 or 1.26 percent since the previous trading session. Looking back, over the last four weeks, AbbVie gained 0.20 percent. Over the last 12 months, its price rose by 18.46 percent. Looking ahead, we forecast AbbVie to be priced at 159.72 by the end of this quarter and at 156.81 in one year, according to Trading Economics global macro models projections and analysts expectations.